Long-duration therapy with low molecular weight heparin in patients with antiphospholipid antibody syndrome resistant to warfarin therapy

被引：35
作者：
Dentali, F
Manfredi, E
Crowther, M
Ageno, W [1 ]
机构：
[1] Univ Insubria, Varese, Italy
[2] McMaster Univ, Hamilton, ON, Canada
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2005年 / 3卷 / 09期
关键词：
D O I：
10.1111/j.1538-7836.2005.01516.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2121 / 2123
页数：3
相关论文
共 11 条
  • [1] The pharmacology and management of the vitamin K antagonists
    Ansell, J
    Hirsh, J
    Poller, L
    Bussey, H
    Jacobson, A
    Hylek, E
    [J]. CHEST, 2004, 126 (03) : 204S - 233S
  • [2] A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome
    Crowther, MA
    Ginsberg, JS
    Julian, J
    Denburg, J
    Hirsh, J
    Douketis, J
    Laskin, C
    Fortin, P
    Anderson, D
    Kearon, C
    Clarke, A
    Geerts, W
    Forgie, M
    Green, D
    Costantini, L
    Yacura, W
    Wilson, S
    Gent, M
    Kovacs, MJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (12) : 1133 - 1138
  • [3] PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES AND VENOUS THROMBOSIS SHOULD RECEIVE LONG-TERM ANTICOAGULANT TREATMENT
    DERKSEN, RHWM
    DEGROOT, PG
    KATER, L
    NIEUWENHUIS, HK
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1993, 52 (09) : 689 - 692
  • [4] A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome(WAPS)
    Finazzi, G
    Marchioli, R
    Brancaccio, V
    Schinco, P
    Wisloff, F
    Musial, J
    Baudo, F
    Berrettini, M
    Testa, S
    D'Angelo, A
    Tognoni, G
    Barbui, T
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (05) : 848 - 853
  • [5] Medical progress: The antiphospholipid syndrome.
    Levine, JS
    Branch, DW
    Rauch, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (10) : 752 - 763
  • [6] Lopaciuk S, 1999, THROMB HAEMOSTASIS, V81, P26
  • [7] ANTIPHOSPHOLIPID THROMBOSIS - CLINICAL COURSE AFTER THE 1ST THROMBOTIC EVENT IN 70 PATIENTS
    ROSOVE, MH
    BREWER, PMC
    [J]. ANNALS OF INTERNAL MEDICINE, 1992, 117 (04) : 303 - 308
  • [8] Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy
    Schulman, S
    Svenungsson, E
    Granqvist, S
    [J]. AMERICAN JOURNAL OF MEDICINE, 1998, 104 (04) : 332 - 338
  • [9] Changes in bone density during long-term administration of low-molecular-weight heparins or acenocoumarol for secondary prophylaxis of venous thromboembolism
    Wawrzynska, L
    Tomkowski, WZ
    Przedlacki, J
    Hajduk, B
    Torbicki, A
    [J]. PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2003, 33 (02) : 64 - 67
  • [10] Wilson WA, 1999, ARTHRITIS RHEUM, V42, P1309, DOI 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO
12